Health Condition 1: F122- Cannabis dependence Health Condition 2: F112- Opioid dependence
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Ready to give informed consent Clinical Opiate Withdrawal Scale Cannabis withdrawal Scale Started on Naltrexone 50mg/day
Exclusion criteria
Exclusion criteria: Any other comorbid substance use excluding caffeine and nicotine Any comorbid psychiatric disorders Any contraindication for undergoing rTMS and MRS Not willing to give informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in level of glutamate & myoinositol at DLPFC after Transcranial magnetic stimulationTimepoint: Baseline and after completion of TMS i.e. after 1 week | — |
Secondary
| Measure | Time frame |
|---|---|
| OCDUS(Obcessive compulsive drug use scale),MCQ(Marijuana craving questionnaire) scoresTimepoint: Baseline & after intervention is over | — |
Countries
India
Contacts
Central institute of psychiatry